Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1β mediated suppression—possible involvement of the mitochondrial membrane potential
Abstract:Aims/hypothesis. We aimed to study the effects of two K ATP channel openers (KCO), diazoxide and the more potent compound NNC 55-0118, on beta-cell suppression and/or toxicity induced by alloxan, sodium nitroprusside and IL-1β. Methods. Islets from rats were exposed to 0.3 mmol/l diazoxide or NNC 55-0118 for 30 min and either alloxan (0.5 mmol/l), sodium nitroprusside (0.5 mmol/l) or IL-1β (12.5 or 25 U/ml) were added and the incubation continued for 30 min. Islets were then washed and incubated for 24 h befor… Show more
“…Diazoxide enhances ischemic preconditioning in the heart (12) and neurons (13,14) through a mitochondrial interaction that may be coupled to reduction of mitochondrial reactive oxygen species production (14). In -cells diazoxide decreases mitochondrial membrane potential in acute experiments (15,16) and may inhibit succinate oxidation (17). We did not observe any effect on gene expression for succinate dehydrogenase, represented in the array by four genes encoding for separate subunits.…”
Diazoxide enhances glucose-induced insulin secretion from -cells through mechanisms that are not fully elucidated. Here, we used microarray analysis (Affymetrix) to investigate effects of diazoxide. Pancreatic islets were cultured overnight at 27, 11, or 5.5 mmol/l glucose with or without diazoxide. Inclusion of diazoxide upregulated altogether 211 genes (signal log 2 ratio >0.5) and downregulated 200 genes (signal log 2 ratio ؊0.5 or lower), and 92% of diazoxide's effects (up-and downregulation) were observed only after coculture with 11 or 27 mmol/l glucose. We found that 11 mmol/l diazoxide upregulated 97 genes and downregulated 21 genes. Increasing the glucose concentration to 27 mmol/l markedly shifted these proportions toward downregulation (101 genes upregulated and 160 genes downregulated). At 27 mmol/l glucose, most genes downregulated by diazoxide were oppositely affected by glucose (80%). Diazoxide influenced expression of several genes central to -cell metabolism. Diazoxide downregulated genes of fatty acid oxidation, upregulated genes of fatty acid synthesis, and downregulated uncoupling protein 2 and lactic acid dehydrogenase. Diazoxide upregulated certain genes known to support -cell functionality, such as NKX6.1 and PDX1. Long-term elevated glucose is permissive for most of diazoxide's effects on gene expression, the proportion of effects shifting to downregulation with increasing glucose concentration. Effects of diazoxide on gene expression could serve to enhance -cell functionality during continuous hyperglycemia. Diabetes 56:1095-1106, 2007 I n previous studies we have documented that pretreatment with diazoxide exerts beneficial effects on glucose-induced insulin secretion (1) and in fact may protect -cells against well-known adverse effects of chronic hyperglycemia. These beneficial effects are only partly related to the preservation of insulin stores (1). Indeed, our previous studies have demonstrated several other effects of potential importance for efficient signal transduction in -cells (1); however, an overview is still lacking. Global gene expression analysis offers an appropriate way to obtain such an overview, and this technique has been used here. On finding a marked glucose dependency for the diazoxide effects on gene expression, we focused further analyses on the interactions of glucose and diazoxide on genes responsible for the metabolism of glucose and other nutrients.
RESEARCH DESIGN AND METHODSDiazoxide (Hyperstat) was from Schering-Plough (Labo, Heist-op-den-Berg, Belgium). Hank's balanced salt solution and RPMI 1640 were purchased from SVA (National Veterinary Institute of Sweden, Uppsala, Sweden). Isolation, culture, and incubation of rat pancreatic islets. Male SpragueDawley rats were purchased from Scanbur (Sollentuna, Sweden). The ethical guidelines of the Karolinska Institute for the care and use of laboratory animals were followed. The rats were maintained in a 12-h (0600 -1800 h) light/dark cycle with free access to water and standard diet. They weighed 250 -35...
“…Diazoxide enhances ischemic preconditioning in the heart (12) and neurons (13,14) through a mitochondrial interaction that may be coupled to reduction of mitochondrial reactive oxygen species production (14). In -cells diazoxide decreases mitochondrial membrane potential in acute experiments (15,16) and may inhibit succinate oxidation (17). We did not observe any effect on gene expression for succinate dehydrogenase, represented in the array by four genes encoding for separate subunits.…”
Diazoxide enhances glucose-induced insulin secretion from -cells through mechanisms that are not fully elucidated. Here, we used microarray analysis (Affymetrix) to investigate effects of diazoxide. Pancreatic islets were cultured overnight at 27, 11, or 5.5 mmol/l glucose with or without diazoxide. Inclusion of diazoxide upregulated altogether 211 genes (signal log 2 ratio >0.5) and downregulated 200 genes (signal log 2 ratio ؊0.5 or lower), and 92% of diazoxide's effects (up-and downregulation) were observed only after coculture with 11 or 27 mmol/l glucose. We found that 11 mmol/l diazoxide upregulated 97 genes and downregulated 21 genes. Increasing the glucose concentration to 27 mmol/l markedly shifted these proportions toward downregulation (101 genes upregulated and 160 genes downregulated). At 27 mmol/l glucose, most genes downregulated by diazoxide were oppositely affected by glucose (80%). Diazoxide influenced expression of several genes central to -cell metabolism. Diazoxide downregulated genes of fatty acid oxidation, upregulated genes of fatty acid synthesis, and downregulated uncoupling protein 2 and lactic acid dehydrogenase. Diazoxide upregulated certain genes known to support -cell functionality, such as NKX6.1 and PDX1. Long-term elevated glucose is permissive for most of diazoxide's effects on gene expression, the proportion of effects shifting to downregulation with increasing glucose concentration. Effects of diazoxide on gene expression could serve to enhance -cell functionality during continuous hyperglycemia. Diabetes 56:1095-1106, 2007 I n previous studies we have documented that pretreatment with diazoxide exerts beneficial effects on glucose-induced insulin secretion (1) and in fact may protect -cells against well-known adverse effects of chronic hyperglycemia. These beneficial effects are only partly related to the preservation of insulin stores (1). Indeed, our previous studies have demonstrated several other effects of potential importance for efficient signal transduction in -cells (1); however, an overview is still lacking. Global gene expression analysis offers an appropriate way to obtain such an overview, and this technique has been used here. On finding a marked glucose dependency for the diazoxide effects on gene expression, we focused further analyses on the interactions of glucose and diazoxide on genes responsible for the metabolism of glucose and other nutrients.
RESEARCH DESIGN AND METHODSDiazoxide (Hyperstat) was from Schering-Plough (Labo, Heist-op-den-Berg, Belgium). Hank's balanced salt solution and RPMI 1640 were purchased from SVA (National Veterinary Institute of Sweden, Uppsala, Sweden). Isolation, culture, and incubation of rat pancreatic islets. Male SpragueDawley rats were purchased from Scanbur (Sollentuna, Sweden). The ethical guidelines of the Karolinska Institute for the care and use of laboratory animals were followed. The rats were maintained in a 12-h (0600 -1800 h) light/dark cycle with free access to water and standard diet. They weighed 250 -35...
“…Overall, these results suggested that diazoxide might be exerting effects independent of the activation of plasma membrane K ATP channels that are responsible for the potentiation of glucose-stimulated DNA synthesis. Findings by Kullin et al (31) also reported that K ATP channel openers including diazoxide decreased the vulnerability of rat islets to free radicals induced by alloxan, nitroprusside, or IL-1. It was proposed that K ATP channel openers by their ability to decrease Ca 2ϩ influx due to -cell membrane hyperpolarization in combination with their direct effect to decrease the mitochondrial membrane potential reduced ATP production necessary for the activation of apoptotic pathways.…”
The aim of this study was to define metabolic signaling pathways that mediate DNA synthesis and cell cycle progression in adult rodent islets to devise strategies to enhance survival, growth, and proliferation. Since previous studies indicated that glucose-stimulated activation of mammalian target of rapamycin (mTOR) 3 H]thymidine incorporation without altering S phase accumulation under chronic elevated glucose, this increase in DNA synthesis also appears to be primarily related to an arrest in S phase and not cell proliferation.Both types 1 and 2 diabetes result from the inability of pancreatic -cells to secrete sufficient amounts of insulin to maintain normal glucose homeostasis due to an acquired secretory defect and/or inadequate -cell mass. Increased metabolic demands or stress responses that exert a positive effect on -cell mass include obesity, pregnancy, partial pancreatectomy, or chronic glucose exposure. -Cell mass is regulated by cellular mechanisms that include replication, neogenesis, hypertrophy, and apoptosis (1, 2). Recent studies have emphasized the importance of the proliferative capacity of existing adult -cells as a major source of new -cells during adult life that may significantly contribute to the maintenance of -cell mass (3).Mammalian target of rapamycin (mTOR) 2 is a serine/threonine protein kinase that integrates signals derived from growth factors and nutrients to regulate cell growth and proliferation through the regulatory proteins 70-kDa ribosomal protein S6 kinase (S6K1) and the eukaryotic initiation factor 4E-binding protein-1 (4EBP1). This signaling cascade stimulates protein translation and increases the capacity of the ribosomal protein machinery necessary for the onset of DNA synthesis (4, 5). Our previous studies have demonstrated that glucose robustly activates mTOR/S6K1/4EBP1 in an amino acid-dependent manner via its metabolism in both rodent and human islets. Glucose and amino acids, especially leucine and glutamate, are the most prominent activators of mTOR in islets, possibly through ATP production mediated by mitochondrial metabolism (6 -9). Insulin secreted by the -cell and growth factors also provide input to mTOR through the insulin signaling cascade to Akt (6). Akt may directly activate mTOR but also has been shown to inhibit the tumor suppressor proteins TSC1/2. These proteins are activated by AMP-dependent protein kinase that is regulated by the ATP/AMP ratio. Rapamycin specifically inhibits mTOR activation and signaling to 4EBP1 and S6K1. Recent reports have demonstrated a negative feedback pathway from chronically stimulated mTOR to IRS2 that inhibits the insulin signaling pathway (10). Apparently, this negative feedback to IRS2 does not reduce nutrient-stimulated mTOR activation in the -cell as S6K1 remains fully activated during a 4-or 6-day exposure to elevated glucose (7), although other IRS2-dependent pathways may be inhibited.Our previous studies demonstrated that the majority of glucose-stimulated [3 H]thymidine incorporation by rodent islets...
“…Recent reports have shown that K ATP channel activation using diazoxide or other selective openers induces -cell rest and protection against the effects of high-fat diet (40)(41)(42). Chronic studies where HCN channel function or expression is manipulated are required to determine the potential roles of these channels on -cell function.…”
Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels mediate the pacemaker current (Ih or If) observed in electrically rhythmic cardiac and neuronal cells. Here we describe a hyperpolarization-activated time-dependent cationic current, beta-Ih, in pancreatic beta-cells. Transcripts for HCN1-4 were detected by RT-PCR and quantitative PCR in rat islets and MIN6 mouse insulinoma cells. beta-Ih in rat beta-cells and MIN6 cells displayed biophysical and pharmacological properties similar to those of HCN currents in cardiac and neuronal cells. Stimulation of cAMP production with forskolin/3-isobutyl-1-methylxanthine (50 microM) or dibutyryl-cAMP (1 mM) caused a significant rightward shift in the midpoint activation potential of beta-Ih, whereas expression of either specific small interfering (si)RNA against HCN2 (siHCN2b) or a dominant-negative HCN channel (HCN1-AAA) caused a near-complete inhibition of time-dependent beta-Ih. However, expression of siHCN2b in MIN6 cells had no affect on glucose-stimulated insulin secretion under normal or cAMP-stimulated conditions. Blocking beta-Ih in intact rat islets also did not affect membrane potential behavior at basal glucose concentrations. Taken together, our experiments provide the first evidence for functional expression of HCN channels in the pancreatic beta-cell.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.